|
Aug 6
|
Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet
|
|
Aug 4
|
Pharming Group to participate in August investor conference
|
|
Aug 2
|
Pharming Group Second Quarter 2025 Earnings: EPS: US$0.007 (vs US$0.002 loss in 2Q 2024)
|
|
Aug 1
|
New Strong Buy Stocks for August 1st
|
|
Jul 31
|
Pharming Group reports second quarter and first half 2025 financial results and provides business update
|
|
Jul 29
|
High Growth Tech Stocks To Watch In Europe July 2025
|
|
Jul 25
|
Best Momentum Stocks to Buy for July 25th
|
|
Jul 22
|
Leigh Syndrome Market Research Report 2025-2035 | Competitive Analysis of PTC Therapeutics, Pharming Group, Edison Pharmaceuticals, Taysha Gene Therapies, and Thiogenesis Therapeutics
|
|
Jul 22
|
Preeclampsia Drug Market Research Report 2025-2035 | Competitive Analysis of Pharming Group, AMAG Pharmaceuticals, Kyowa Kirin, and Baxter
|
|
Jul 17
|
New Strong Buy Stocks for July 17th
|
|
Jul 17
|
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
|
|
Jun 24
|
Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis
|
|
Feb 20
|
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
|
|
Feb 11
|
High Growth Tech And These 3 Dynamic Stocks with Promising Expansion
|
|
Feb 10
|
Pharming Group to participate in February investor conference
|
|
Oct 10
|
Pharming Group to report third quarter 2024 financial results on October 24
|
|
Feb 8
|
Pharming Group to participate in February investor conferences
|
|
Apr 26
|
Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023
|